Skip to main content

Upcoming holiday closures 

Quest Patient Service Centers will be closed on Friday, July 3 and Saturday, July 4, 2026, in observance of Independence Day, and to give our frontline team the time to recharge. Don't let the holiday interrupt your care. Plan your visit today.

Hide
Quest Diagnostics

IL-1 Receptor 1 Signaling Shapes the Development of Viral Antigen-Specific CD4+ T Cell Responses Following COVID-19 mRNA Vaccination

IL-1 Receptor 1 Signaling Shapes the Development of Viral Antigen-Specific CD4+ T Cell Responses Following COVID-19 mRNA Vaccination

Authors: Park HJ, Shin MS, Shin JJ, Kim H, Kang B, Par-Young J, Unlu S, Afinogenova Y, Catanzaro J, Young J, Kim M, Lee SJ, Jeon S, You S, Racke MK, Bucala R, Kang I

Citation: EBioMedicine. 2024 Apr 18;103:105114. doi: 10.1016/j.ebiom.2024.105114. Online ahead of print.

Specialties: Infectious disease, COVID-19, Immunology

Related content

Publication
Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection
Publication
Assessing vulnerability to COVID 19 in high risk populations: the role of SARS CoV 2 spike targeted serology
Publication
SARS-CoV-2 Spike-Protein Targeted Serology Test Results and Their Association With Subsequent COVID-19-Related Outcomes
Publication
Prior cycles of anti-CD20 antibodies affect antibody responses after repeated SARS-CoV-2 mRNA vaccination
Publication
Microfluidic immuno-serolomic assay reveals systems level association with COVID-19 pathology and vaccine protection
Publication
Comparison of SARS-CoV-2 RT-PCR Ct values across multiple assays with different targets
Publication
New diagnosis of systemic lupus erythematosus after COVID-19 vaccination: A case report and review of literature

Related content

Conference Presentation
SARS-CoV-2 mRNA Vaccination Affects Antibody and Cellular Immune Responses After B-Cell Depletion Therapies
Publication
Defining Clinical and Immunological Predictors of Poor Immune Responses to COVID-19 mRNA Vaccines in Patients with Primary Antibody Deficiency
Conference Presentation
Correlates of immunity in SARS-CoV-2 post-vaccine infectious in the Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) Study
Publication
SARS-CoV-2 Spike-Protein Targeted Serology Test Results and Their Association With Subsequent COVID-19-Related Outcomes

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.